enGene Holdings Inc. (ENGN)

Profile

Full Name

enGene Holdings Inc.

Ticker

NASDAQ: ENGN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Canada

IPO

February 1, 2022

Indexes

Not included

Website

https://www.engene.com

Employees

56

Key Details

Price

$5.43(+4.83%)

Market cap

$277.50M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$1.46(+99.03% YoY)

PE ratio

-

Next earnings date

Sep 10, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $5.43
    ENGN price is $5.43

    30-Day Relative Volume

    0.85
    ENGN 30-day relative volume is 0.85

    Price Performance

    Price Most recent change

    +4.83%
    ENGN price was up +4.83% on Sep 8, 2025

    Price YTD change

    -18.35%
    ENGN price is down -18.35% since January 1st

    Price 1-year change

    -17.48%
    ENGN price is down -17.48% year-on-year

    Price 3-year change

    -46.13%
    ENGN price is down -46.13% over the past 3 years

    Price Range

    Price All-time high

    $47.17
    ENGN price is currently -88.49% below its historical high of $47.17

    Price 3-year low

    $2.65
    ENGN price is currently +104.91% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $277.50M
    ENGN market capitalization is $277.50 million

    Market cap 3-year change

    +117.63%
    ENGN market capitalization is up +117.63% over the past 3 years

    Market cap All-time high

    $794.92M
    ENGN market capitalization is currently -65.09% below its historical high of $794.92 million

    Market cap sector rank

    55.42%
    ENGN market capitalization is higher than 55.42% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +15.58%
    ENGN shares outstanding is up +15.58% year-on-year

    Shares Outstanding 3-Year Change

    +303.99%
    ENGN shares outstanding is up +303.99% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.28
    ENGN beta is 0.28

    200-day SMA

    $5.07
    ENGN price is currently +7.09% above its 200-day simple moving average

    50-day SMA

    $3.93
    ENGN price is currently +38.26% above its 50-day simple moving average

    RSI

    82.77
    ENGN 14-day relative strength index is 82.77

    Volume

    0.85
    ENGN 30-day relative volume is 0.85

    ATR

    $0.38
    ENGN average true range is $0.38

    10-day Historical Volatility

    53.97%
    ENGN 10-day historical volatility is 53.97%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    ENGN annual revenue is $0.00

    Revenue Analysts estimate

    -
    ENGN annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    ENGN annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.79%
    ENGN annual revenue is higher than 28.79% of companies in Healthcare sector

    EPS

    EPS

    -$1.46
    ENGN annual earnings per share is -$1.46

    EPS Analysts estimate

    -$1.98
    ENGN annual earnings per share is currently -26.41% lower than the consensus analysts' forecast

    EPS 1-year change

    +99.03%
    ENGN annual earnings per share is up +99.03% year-on-year

    EPS Sector rank

    43.53%
    ENGN annual earnings per share is higher than 43.53% of companies in Healthcare sector

    Profit

    Gross profit

    -$323.00K
    ENGN annual gross profit is -$323.00 thousand

    Gross margin

    -
    ENGN annual gross profit margin value is unknown

    Operating profit

    -$62.30M
    ENGN annual operating income is -$62.30 million

    Operating margin

    -
    ENGN annual operating profit margin value is unknown

    Net income

    -$55.14M
    ENGN annual net profit is -$55.14 million

    Net margin

    -
    ENGN annual net profit margin value is unknown

    Expenses

    Total expenses

    $55.14M
    ENGN annual total expenses is $55.14 million

    Operating expenses

    $61.97M
    ENGN annual total operating expenses is $61.97 million

    Cost of goods sold

    $323.00K
    ENGN annual cost of goods sold is $323.00 thousand

    Selling, general & administrative expenses

    $0.00
    ENGN annual SGA is $0.00

    Depreciation and amortization

    $323.00K
    ENGN annual depreciation & amortization is $323.00 thousand

    Interest expense

    $0.00
    ENGN annual interest expense is $0.00

    Income tax

    -$19.00K
    ENGN annual income tax is -$19.00 thousand

    EBIT & EBITDA

    EBIT

    -$62.30M
    ENGN annual earnings before interest & taxes is -$62.30 million

    EBITDA

    -$61.97M
    ENGN annual EBITDA is -$61.97 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $311.17M
    ENGN annual total assets is $311.17 million

    Non current assets

    $63.81M
    ENGN annual long term assets is $63.81 million

    Current assets

    $247.36M
    ENGN annual total current assets is $247.36 million

    Cash and cash equivalents

    $238.40M
    ENGN annual cash & cash equivalents is $238.40 million

    Accounts receivable

    -
    ENGN annual accounts receivable value is unknown

    Inventory

    $0.00
    ENGN annual inventory is $0.00

    Liabilities

    Total liabilities

    $38.56M
    ENGN annual total liabilities is $38.56 million

    Long term liabilities

    $23.90M
    ENGN annual total long term liabilities is $23.90 million

    Current liabilities

    $14.66M
    ENGN annual total current liabilities is $14.66 million

    Accounts payable

    $1.41M
    ENGN annual accounts payable is $1.41 million

    Debt

    Total debt

    $25.02M
    ENGN annual total debt is $25.02 million

    Total debt 1-year change

    +155.9%
    ENGN annual total debt is up +155.9% year-on-year

    Long term debt

    $23.90M
    ENGN annual long term debt is $23.90 million

    Short term debt

    $1.12M
    ENGN annual short term debt is $1.12 million

    Equity & Capital

    Shareholders equity

    $272.61M
    ENGN annual stockholders equity is $272.61 million

    Book value

    $272.61M
    ENGN annual book value is $272.61 million

    Retained earnings

    -$254.73M
    ENGN annual retained earnings is -$254.73 million

    Working capital

    $232.70M
    ENGN annual working capital is $232.70 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$48.28M
    ENGN annual cash flow from operations is -$48.28 million

    Cash from operations 1-year change

    -95.13%
    ENGN annual cash flow from operations is down -95.13% year-on-year

    Cash from investing

    -$125.95M
    ENGN annual cash flow from investing activities is -$125.95 million

    Cash from investing 1-year change

    -39507.86%
    ENGN annual cash flow from investing activities is down -39507.86% year-on-year

    Cash from financing

    $265.72M
    ENGN annual cash flow from financing activities is $265.72 million

    Cash from financing 1-year change

    +208.44%
    ENGN annual cash flow from financing activities is up +208.44% year-on-year

    CAPEX

    CAPEX

    $925.00K
    ENGN annual capital expenditures is $925.00 thousand

    CAPEX 1-year change

    +190.88%
    ENGN annual capital expenditures is up +190.88% year-on-year

    Free Cash Flow

    Free cash flow

    -$49.21M
    ENGN annual free cash flow is -$49.21 million

    Free cash flow 1-year change

    -96.34%
    ENGN annual free cash flow is down -96.34% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ENGN annual gross profit margin value is unknown

    Operating margin

    -
    ENGN annual operating profit margin value is unknown

    Net margin

    -
    ENGN annual net profit margin value is unknown

    ROA & ROE

    ROA

    -27.70%
    ENGN annual return on assets is -27.70%

    ROE

    -31.96%
    ENGN annual return on equity is -31.96%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ENGN price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ENGN price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.22
    ENGN price to book ratio is 1.22

    PB ratio Sector rank

    38.97%
    ENGN price to book ratio is higher than 38.97% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    ENGN price to sales ratio value is unknown

    PS ratio Sector rank

    -
    ENGN price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $85.40M
    ENGN enterprise value is $85.40 million

    Enterprise value Sector rank

    45.19%
    ENGN enterprise value is higher than 45.19% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.98
    ENGN EV/EBITDA is -0.98

    EV/EBITDA Sector rank

    47.36%
    ENGN EV/EBITDA is higher than 47.36% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    16.87
    ENGN annual current ratio is 16.87

    Quick ratio

    16.87
    ENGN annual quick ratio is 16.87

    Leverage

    Debt to equity

    0.09
    ENGN annual debt to equity ratio is 0.09

    Interest coverage ratio

    -
    ENGN annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    ENGN piotroski f-score value is unknown

    Altman Z-Score

    3.41
    ENGN altman z-score is 3.41

    Analyst ratings

    Recent major analysts updates

    Apr 29, 25 JMP Securities
    Market Outperform
    Mar 11, 25 Morgan Stanley
    Overweight
    Mar 11, 25 HC Wainwright & Co.
    Buy
    Feb 18, 25 Piper Sandler
    Overweight
    Feb 14, 25 UBS
    Neutral
    Dec 23, 24 JMP Securities
    Market Outperform
    Dec 23, 24 HC Wainwright & Co.
    Buy
    Dec 6, 24 JMP Securities
    Market Outperform
    Nov 27, 24 Raymond James
    Outperform
    Nov 18, 24 JMP Securities
    Market Outperform

    Institutional Ownership

    Screeners with ENGN included

    Growing Shares Outstanding
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Canadian stocks
    Stocks below analysts price target
    Healthcare sector
    All stocks
    High Altman Z score stocks
    • What is the ticker symbol for enGene Holdings Inc.?
    • Does enGene Holdings Inc. pay dividends?
    • What sector is enGene Holdings Inc. in?
    • What industry is enGene Holdings Inc. in?
    • What country is enGene Holdings Inc. based in?
    • When did enGene Holdings Inc. go public?
    • Is enGene Holdings Inc. in the S&P 500?
    • Is enGene Holdings Inc. in the NASDAQ 100?
    • Is enGene Holdings Inc. in the Dow Jones?
    • When was enGene Holdings Inc.'s last earnings report?
    • When does enGene Holdings Inc. report earnings?

    What is the ticker symbol for enGene Holdings Inc.?

    The ticker symbol for enGene Holdings Inc. is NASDAQ:ENGN

    Does enGene Holdings Inc. pay dividends?

    No, enGene Holdings Inc. does not pay dividends

    What sector is enGene Holdings Inc. in?

    enGene Holdings Inc. is in the Healthcare sector

    What industry is enGene Holdings Inc. in?

    enGene Holdings Inc. is in the Biotechnology industry

    What country is enGene Holdings Inc. based in?

    enGene Holdings Inc. is headquartered in Canada

    When did enGene Holdings Inc. go public?

    enGene Holdings Inc.'s initial public offering (IPO) was on February 1, 2022

    Is enGene Holdings Inc. in the S&P 500?

    No, enGene Holdings Inc. is not included in the S&P 500 index

    Is enGene Holdings Inc. in the NASDAQ 100?

    No, enGene Holdings Inc. is not included in the NASDAQ 100 index

    Is enGene Holdings Inc. in the Dow Jones?

    No, enGene Holdings Inc. is not included in the Dow Jones index

    When was enGene Holdings Inc.'s last earnings report?

    enGene Holdings Inc.'s most recent earnings report was on June 12, 2025

    When does enGene Holdings Inc. report earnings?

    The next expected earnings date for enGene Holdings Inc. is September 10, 2025
    On this page